Indolyl-containing RORγt inhibitors
US9861612B2 · kind B2 · utility
0Cited by
0References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 8, 2016 |
| Grant date | Jan 9, 2018 |
| Priority date | — |
| Expiry date | Nov 8, 2036 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D487/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to compounds of formula (I), wherein R1 and R2 are as defined herein. The compounds of the invention are inhibitors of RORγt and are useful in the treatment of diseases and conditions mediated by RORγt.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.